Events & learning

Events

Lighting up Neurobiology with Antibodies

A June 2024 symposium to illuminate how imaging technologies are driving discovery in neurobiology.

View event
A graphic that reads, "Welcome to IPI Surfacing, a symposium on cell surface receptor biology and protein science"

IPI Surfacing

Watch recorded talks and view posters from our June 2023 symposium on cell surface receptor biology.

View event

Core concepts

Three-dimensional rendering of a glypican receptor.
Glypicans: Explained

Hundreds of millions of years before humans evolved, a family of proteins came to be…

Illustration of an epitope tag antibody recognizing the epitope tag sequence at a N- or C-terminus.
Epitope tags: Explained

IPI epitope tag antibodies, delivered via an open science model, aim to increase access, cut…

Scientist viewing robot in lab.
Engineering Protein A to Z for VH3 antibody purification

Antibody purification is often taken for granted. It’s an essential step in isolating desirable antibodies…

IPI talks

Debora Marks at IPI: Generative models for prediction and design
Shaotong Zhu, IPI Principal Scientist, talking about IPI's opioid research
IPI cell surface receptor research and the opioid crisis
A thumbnail image for "The journey to IPI" talk by Tim Springer
Tim Springer’s journey to IPI
Andreas Plückthun at IPI Surfacing: Forcing actions on surface receptors by engineered binding molecules
Yvonne Jones at IPI Surfacing: Some structural stories from the cell surface
Junichi Takagi at IPI Surfacing: The “Lasso-grafted” Fc design platform offers creation of novel receptor agonists and antagonists
Christopher Garcia at IPI Surfacing: Modulating cell physiology through ligand-receptor engineering
An image showing the headshots and titles of the six members who spoke as part of the IPI Surfacing panel discussion. These include: Errik Anderson, Alloy Therapeutics. Aled Edwards, University of Toronto and the Structural Genomics Consortium. Andrew Kruse, Harvard Medical School. Rob Meijers, Institute for Protein Innovation. Andreas Plückthun, University of Zurich. Meghan Rego, Addgene.
IPI Surfacing panel discussion: The promise of synthetic antibodies and the challenges to universal access
Back To Top